Personal information

No personal information available

Activities

Education and qualifications (1)

University of Kentucky: Lexington, KY, US

1993-09-01 to present | PhD (Anatomy and Neuroscience)
Education
Source: Self-asserted source
Don Gash

Works (20)

Point source concentration of GDNF may explain failure of phase II clinical trial

Experimental neurology
2006 | Journal article
Source: Self-asserted source
Don Gash

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

Journal of neurosurgery
2005 | Journal article
Source: Self-asserted source
Don Gash

Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

Proceedings of the National Academy of Sciences
2004 | Journal article
Source: Self-asserted source
Don Gash

Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects

Journal of Comparative Neurology
2003 | Journal article
Source: Self-asserted source
Don Gash

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

Brain
2002 | Journal article
Source: Self-asserted source
Don Gash

Critical decline in fine motor hand movements in human aging

Neurology
1999 | Journal article
Source: Self-asserted source
Don Gash

Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease

Annals of neurology
1999 | Journal article
Source: Self-asserted source
Don Gash

Principal component analysis of the dynamic response measured by fMRI: a generalized linear systems framework

Magnetic Resonance Imaging
1999 | Journal article
Source: Self-asserted source
Don Gash

Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease

Journal of neurology
1998 | Journal article
Source: Self-asserted source
Don Gash

Neuroprotective and neurorestorative properties of GDNF

Annals of neurology
1998 | Journal article
Source: Self-asserted source
Don Gash

GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis

The Journal of neuroscience
1997 | Journal article
Source: Self-asserted source
Don Gash

Functional recovery in parkinsonian monkeys treated with GDNF

1996 | Journal article
Source: Self-asserted source
Don Gash

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

Brain research
1995 | Journal article
Source: Self-asserted source
Don Gash

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

Annals of neurology
1994 | Journal article
Source: Self-asserted source
Don Gash

Disruption of the blood-brain barrier as the primary effect of CNS irradiation

Radiotherapy and Oncology
1994 | Journal article
Source: Self-asserted source
Don Gash

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

Annals of neurology
1991 | Journal article
Source: Self-asserted source
Don Gash

Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration

Experimental neurology
1988 | Journal article
Source: Self-asserted source
Don Gash

Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes

Journal of Comparative Neurology
1988 | Journal article
Source: Self-asserted source
Don Gash

Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers

Science
1987 | Journal article
Source: Self-asserted source
Don Gash

Functional development of grafted vasopressin neurons

Science
1980 | Journal article
Source: Self-asserted source
Don Gash